Impact of Multitiered Copayments on the Use and Cost of Prescription Drugs among Medicare Beneficiaries

Abstract

Higher tiered drug plans reduce overall expenditures and the number of prescriptions purchased by Medicare beneficiaries. Beneficiaries are less responsive to cost sharing incentives when using drugs to treat chronic conditions.